GLP-1 TV · 9 videos · most watched first · views checked Oct 2026
CagriSema explained videos
CagriSema is not FDA-approved, so these are trial readouts and clinician explainers only, never personal-use videos. How it works and what the trials found. 9 videos, 70K views between them; clinicians are labelled. For the label facts in writing, read our our guide.
4:05Cagrilintide - New Rx? (Obesity Doctor)Weight Medicine with Dr. Meghan MDDetails4 key moments
A clinician (MD) explains how a GLP-1 works and what the evidence says.
- 0:00 Introduction to krillintide
- 0:39 What is krillintide?
- 1:23 How krillintide works
- 2:28 Future combined treatments
- Who is speaking: Clinician, MD
13:02CAGRISEMA: Breaking Down NEW Weight-Loss Solution | Obesity Medicine | Dr. Dan Obesity ExpertDr. Dan | Obesity ExpertDetails
A clinician explains how a GLP-1 works and what the evidence says. It has no captions we could read, so this is drawn from its title and description.
- Who is speaking: Clinician (Dr. Dan)
49:34Reatrutide + Cagrilintide Scientific Study?!On The Pen™ GLP-1 NewsDetails
A news or media piece explains how a GLP-1 works and what the evidence says. Also covers the trials.
- Who is speaking: News or media
17:36Mounjaro vs CagriSema: O Que os Estudos MostramGi BettinDetails5 key moments
A patient explains how Mounjaro works and what the evidence says. It has no captions we could read, so this is drawn from its title and description.
- 0:00 O que é a Cagrisema e como ela funciona?
- 2:09 A ciência por trás da combinação hormonal
- 3:58 Análise dos estudos Redefine e Reimagine
- 6:38 Cagrisema vs. Mounjaro: Quem vence a disputa?
- 8:35 Expectativas para a chegada no mercado
- Who is speaking: Patient
1:05:04Zepbound VS Cagrisema: Novo BESTED Lilly? Not so Fast…On The Pen™ GLP-1 NewsDetails
A news or media piece explains how Zepbound works and what the evidence says. It has no captions we could read, so this is drawn from its title and description.
- Who is speaking: News or media
24:38**NEW** Cagrisema Data!On The Pen™ GLP-1 NewsDetails7 key moments
A news or media piece explains how a GLP-1 works and what the evidence says, mentioning 15 mg. Side effects mentioned: fatigue. Also covers food noise and cravings, cost and insurance and stopping and maintenance ($50 a month mentioned).
- 0:00 Video introduction
- 3:02 Medicare coverage update
- 8:01 Kaggrama data release
- 10:39 Market and youth usage
- 13:24 Personal experience and risks
- 17:31 Hunger management and products
- 22:53 Future pipeline and wrap up
- Doses mentioned: 15 mg
- Side effects mentioned: fatigue
- Prices mentioned: $50 a month
- Who is speaking: News or media
7:53CagriSema Dr EXPLAINS How This GLP 1 + Amylin Drug Differs From WegovyDr. G's Lifestyle Medicine NetworkDetails8 key moments
A clinician explains how Wegovy works and what the evidence says. Also covers food, protein and eating, food noise and cravings and the trials ($300 a month and $400 a month mentioned).
- 0:00 Introduction to Kagrama
- 0:21 Mechanism of action
- 1:34 Clinical trial data
- 3:14 Outperforming monotherapy
- 4:04 Patient impact and limits
- 4:42 Safety and health management
- 5:49 Future and implementation
- 6:55 Takeaways and contact
- Prices mentioned: $300 a month and $400 a month
- Who is speaking: Clinician (Dr. G's Lifestyle)
2:18#zepbound vs #cagrisema ( #Wegovy / cagrilintide combo) Head to Head in new phase 3 trial!On The Pen™ GLP-1 NewsDetails
A news or media piece explains how Wegovy works and what the evidence says, mentioning 2.4 mg. Also covers the trials.
- Doses mentioned: 2.4 mg
- Who is speaking: News or media
4:35Doctor Reviews Cagrisema: New Boosted Ozempic!Dr KiddDetails3 key moments
A clinician explains how Ozempic works and what the evidence says. Side effects mentioned: nausea and vomiting. Also covers food noise and cravings and the trials.
- Side effects mentioned: nausea and vomiting
- Who is speaking: Clinician (Dr Kidd)
Watched enough? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.